Amperos Health | $4,200,000 | (Jun 5, 2025)
Manex AI | $9,142,230 | (Jun 5, 2025)
fabriq | $25,000,000 | (Jun 5, 2025)
Certified by Founder
Lodge
HI-Bio
start up
United States
- South San Francisco, California
- 05/01/2024
- Series B
- $95,000,000
Human Immunology Biosciences (HI-Bio) is leading clinical immunology into its next chapter with therapies that target cellular drivers of disease. HI-Bio uses a precision medicine approach to deliver therapies for patients with the auto-immune, allergic and inflammatory diseases that can together be referred to as immune-mediated diseases (IMDs).
- Industry Biotechnology Research
- Website https://hibio.com/
- LinkedIn https://www.linkedin.com/company/hibio/about/
Obvio | $22,000,000 | (Jun 5, 2025)
Portless | $18,000,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)
Delpha | $2,000,000 | (Jun 5, 2025)
Compyl | $12,000,000 | (Jun 4, 2025)
Ciroos | $21,000,000 | (Jun 4, 2025)
Clara(US) | $3,100,000 | (Jun 4, 2025)
myLaurel® | $12,000,000 | (Jun 4, 2025)